In this study of at-risk children with AD, we find that the FLG null defines an endotype characterized by dermatitis with a predilection site at exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and chronic morphological markers. This evidence concerns the gene FLG and dermatitis.